Branchiooculofacial syndrome is a rare genetic condition that affects the skin, face, eyes, and neck. People with Branchiooculofacial syndrome often have small pits or cysts on the neck, cleft lip or palate, and eye differences that can affect vision. Features are present from birth and are lifelong, but not everyone will have the same experience. Most people with Branchiooculofacial syndrome have a normal life span, though they may need multiple surgeries and regular eye, hearing, and dental care. Treatment focuses on managing features over time, including cleft repair, hearing support, eye protection, and dental or orthodontic care.
Overview
Branchiooculofacial syndromeSymptoms
Branchiooculofacial syndrome usually shows at birth with neck pits or fistulas, cleft lip/palate, distinctive nose and hairline, and eye differences like small eyes or coloboma. Hearing loss and dental anomalies are common. Early signs of Branchiooculofacial syndrome vary in severity.
Outlook and prognosis
Many living with Branchiooculofacial syndrome grow well with coordinated care, especially for hearing, vision, and craniofacial differences. Early surgery, hearing support, and eye monitoring can protect development and learning. Lifespan is typically near typical when complications are managed.
Causes and risk factors
Branchiooculofacial syndrome typically results from a change in the TFAP2A gene. Most cases are new (de novo); a parent with BOFS has a 50% chance to pass it on. No proven environmental or lifestyle risk factors are known.
Genetic influences
Genetics are central in Branchiooculofacial syndrome, which is typically inherited in an autosomal dominant pattern. Most cases involve variations in the TFAP2A gene that alter facial, ear, eye, and neck development. Some arise from new (de novo) variants without family history.
Diagnosis
Doctors usually make the diagnosis of Branchiooculofacial syndrome based on characteristic birth features of the face, eyes, and neck. Genetic tests can confirm it and help rule out similar conditions. Imaging or specialist exams may document specific findings.
Treatment and drugs
Treatment for Branchiooculofacial syndrome focuses on each person’s needs, often starting in childhood. Care may include eye protection or surgery, repairing cleft lip/palate, treating neck cysts, hearing support, dental/orthodontic care, and speech and developmental therapies. Regular follow-up with a coordinated team helps.
Symptoms
Many babies with Branchiooculofacial syndrome are born with noticeable differences in the face, eyes, or neck. Parents may notice early features of Branchiooculofacial syndrome, such as small pits or patches on the neck, watery or light-sensitive eyes, or a cleft lip or palate that can make feeding harder. Features vary from person to person and can change over time. As children grow, vision, hearing, dental, and speech needs often guide day-to-day care and follow-up.
A split in the upper lip or the roof of the mouth can be present at birth, which can make latching and feeding more difficult. In Branchiooculofacial syndrome, early repair and feeding support can reduce choking, nasal regurgitation, and help growth.
Some have a small eye, a notch in the colored part or eyelids, or eyelids that do not close fully. Clinicians call this a coloboma, which means a gap in eye structures present from birth.
Tears may not drain well, leading to watery eyes, crusting, or infections near the inner corner. Gentle massage, eyedrops, or a minor procedure may be recommended if it does not improve.
Small openings, pits, or red patches on the side of the neck can leak fluid or become infected. Careful skin care and, at times, surgery can help prevent problems.
How people usually first notice Branchiooculofacial syndrome?
Many families first notice branchiooculofacial syndrome shortly after birth when a baby has distinctive facial features, such as a broad nasal bridge, widely spaced eyes, a cleft lip and/or palate, or small skin tags or pits near the ears or along the neck. Newborn hearing checks may suggest hearing loss, and eye findings like small eyes (microphthalmia), blocked tear ducts, or unusual-looking eyelids can prompt an early eye exam. Doctors often connect these first signs of branchiooculofacial syndrome during the initial newborn assessments or early well-baby visits, sometimes supported by prenatal ultrasound clues if a cleft or facial differences were seen before birth.
Types of Branchiooculofacial syndrome
Branchiooculofacial syndrome is a rare genetic condition with a recognizable pattern of features affecting the skin of the neck, eyes, and facial development. Most cases are linked to changes in the TFAP2A gene, and symptoms can vary from mild to more pronounced even within the same family. People may notice different sets of symptoms depending on their situation. When people look up types of Branchiooculofacial syndrome, they’re usually asking about clinical variants tied to the specific gene change and how strongly features show up, rather than entirely separate subtypes.
Classic TFAP2A-related
This variant includes the well-known combination of neck pits or cysts, eye differences, and clefting or dental changes. Hearing loss and distinctive facial shape are common, with severity ranging from mild to significant.
Milder expressivity
Features are present but subtler, such as small neck pits, mild eyelid or tear duct differences, or minor dental changes. Clefting may be absent, and hearing can be normal or only slightly affected.
Severe expressivity
Multiple areas are more strongly affected, with broader or deeper branchial skin tracts, marked eye differences, and cleft lip and/or palate. Feeding, breathing, or speech issues may need earlier treatment and coordinated care.
De novo versus inherited
Many have a new (de novo) change in TFAP2A with no family history, while others inherit it in an autosomal dominant pattern. Symptoms in inherited cases can differ widely between relatives despite the same underlying variant.
What genetics can tell you about symptoms
Some people with Branchiooculofacial syndrome who carry TFAP2A gene changes develop branchial cleft pits or cysts in the neck and small openings near the ears, while others show eye differences like widely spaced eyes, droopy lids, or blocked tear ducts. Specific variants can also affect facial development, leading to cleft lip and/or palate and a broad nasal bridge.
Causes and risk factors
Branchiooculofacial syndrome is usually caused by a change in the TFAP2A gene.
It is inherited in an autosomal dominant way, and many cases start as a new mutation with no family history.
The same gene change can lead to different features and early symptoms of Branchiooculofacial syndrome.
If a parent has the change, each child has a 50% chance to inherit it, and rarely the change is present only in eggs or sperm in a parent without signs.
Genes set the stage, but environment and lifestyle often decide how the story unfolds.
Environmental and biological risk factors
Branchiooculofacial syndrome develops before birth during the earliest weeks of facial and neck formation. For most families, there isn’t a single clear exposure that explains why it happens. Some risks are carried inside the body, others come from the world around us. Here are environmental and biological factors that can influence how likely this condition is to occur, rather than early symptoms of Branchiooculofacial syndrome.
As men get older, sperm cells keep dividing and tiny copying errors become more common. This slightly raises the chance of a new gene change that could lead to Branchiooculofacial syndrome. The overall risk remains low for any one pregnancy.
Occasionally, a DNA change happens by chance when an egg or sperm is formed. This biological event can lead to the condition even with no known triggers. It is not caused by something the pregnant parent did or did not do.
Significant radiation to a parent’s pelvis or to the testes or ovaries before conception can damage DNA in sperm or eggs. This may slightly increase the chance of a new gene change, though the absolute risk of Branchiooculofacial syndrome remains very low. Routine X-rays and CT scans use much lower doses than cancer radiotherapy.
Genetic risk factors
Changes in a single gene called TFAP2A are the known genetic cause of Branchiooculofacial syndrome. The condition follows an autosomal dominant pattern, so one altered copy can be enough to cause it, and many cases arise as a new (de novo) change with no prior family history. People with the same risk factor can have very different experiences.
TFAP2A gene changes: Variants in TFAP2A are the primary cause of Branchiooculofacial syndrome. This gene helps guide early development of the head, neck, and eyes.
Autosomal dominant inheritance: A single altered copy can cause the condition. If a parent carries the change, each child has a 50% (1 in 2) chance of inheriting it. Severity can differ even within a family.
De novo variants: Many people with Branchiooculofacial syndrome have a TFAP2A change that is new to the family. The change arises in an egg, sperm, or just after conception. Recurrence risk is usually low but not zero.
Germline mosaicism: A parent may carry the change in some egg or sperm cells but not in blood testing, called germline mosaicism. This rare situation can lead to more than one affected child despite negative parental tests.
Somatic mosaicism: Some individuals have the TFAP2A change in only a portion of body cells. Features can be milder or patchy, and early symptoms of Branchiooculofacial syndrome may be subtle. Testing affected tissue can sometimes help confirm the change.
Copy-number changes: Occasionally, a larger missing piece or a rearrangement that includes TFAP2A causes Branchiooculofacial syndrome. These structural changes also disrupt the gene’s function and lead to similar features.
Variable expressivity: The same TFAP2A change can lead to different features and severity in Branchiooculofacial syndrome. This unpredictability makes precise outcome forecasting difficult before or during pregnancy.
Family history: Having an affected parent or close relative increases the chance of sharing the same TFAP2A change. Still, many families have no history because the change first occurred in a child.
Genetic testing: Targeted genetic testing for Branchiooculofacial syndrome looks for changes in TFAP2A. Results can confirm the diagnosis and clarify inheritance risks for relatives.
Lifestyle risk factors
Lifestyle habits do not cause Branchiooculofacial syndrome, but day‑to‑day choices can influence symptom control, growth, and complications. Tailoring routines to feeding, airway, eye, ear, skin, and kidney needs can support health and development. This section explains how lifestyle affects Branchiooculofacial syndrome and highlights practical areas to focus on.
Texture‑appropriate, calorie‑dense meals can improve growth when clefting or swallowing issues make eating hard. Working with safe swallowing strategies lowers aspiration risk during feeds.
Meticulous brushing and flossing reduce cavities and gum disease that can jeopardize teeth near cleft repair sites. Good oral care supports future orthodontic work and surgical outcomes.
Daily home practice of therapist‑taught exercises strengthens articulation and resonance after cleft repair. Consistency can speed communication gains and reduce frustration.
Gentle cleansing and moisturization around branchial pits and scars lower irritation and infection risk. Prompt care of any drainage helps protect healing tissues.
Risk prevention
For Branchiooculofacial syndrome, you can’t fully prevent the condition itself because it’s genetic, but you can lower the risk of complications and protect long‑term health. Acting early often makes daily life easier—think feeding, breathing, hearing, vision, and skin care. Parents and clinicians watching for early symptoms of Branchiooculofacial syndrome can move quickly on supports that matter most. Prevention works best when combined with regular check-ups.
Meet with a genetics team to understand inheritance and risks to future pregnancies. Discuss options like prenatal testing and IVF with embryo testing.
See a coordinated team (genetics, ENT, eye, craniofacial, kidney) soon after diagnosis. Early planning helps prevent avoidable complications in Branchiooculofacial syndrome.
Schedule early eye exams to check for structure and vision differences. Use protective eyewear and prompt treatment to prevent injuries, dryness, or infection that can worsen vision.
Get newborn and repeat hearing checks, since hearing loss can be subtle at first. Treat ear infections quickly and avoid loud noise or ear‑toxic medicines when possible.
Transmission
Branchiooculofacial syndrome is not infectious—you can’t catch it or pass it on through contact, coughs, or body fluids. It is a genetic condition that is usually inherited in an autosomal dominant way, which means if a parent has Branchiooculofacial syndrome, each child has a 50% chance of inheriting it. Many people with Branchiooculofacial syndrome are the first in their family to have it because of a new genetic change, so there may be no family history. If neither parent is affected, the chance of genetic transmission of Branchiooculofacial syndrome in another pregnancy is usually low, though a genetics professional can explain the small possibility of a hidden change in a parent’s eggs or sperm.
When to test your genes
Consider genetic testing if you have features suggestive of Branchiooculofacial syndrome—such as branchial cleft anomalies, distinctive facial differences, or eye findings—or a close relative with a confirmed diagnosis. Testing is also useful before pregnancy or during family planning to clarify inheritance and recurrence risk. Early confirmation guides tailored monitoring for hearing, airway, eye health, and surgical planning.
Diagnosis
For most people, the path to diagnosis starts when a pattern of changes across the neck, eyes, and face is noticed in infancy or early childhood. Doctors then confirm the suspected condition with targeted tests. Early and accurate diagnosis can help you plan ahead with confidence. The genetic diagnosis of Branchiooculofacial syndrome is usually confirmed by testing the TFAP2A gene after a specialist exam points in this direction.
Providers look for a consistent combination of neck pits or cysts, eye differences, and facial changes such as a cleft lip or palate. This recognizable pattern raises suspicion for Branchiooculofacial syndrome.
A genetics or craniofacial team performs a head-to-toe assessment, including the skin along the neck, the eyes and lids, the ears, and the mouth and palate. Photos and detailed measurements may help document key features.
A blood or saliva test checks the TFAP2A gene for a spelling change or a missing/extra segment. Finding a disease-causing change confirms the diagnosis and can guide family testing.
Sometimes a broader craniofacial or branchial-arch gene panel is used when features overlap with other conditions. This approach can speed answers when several syndromes are being considered.
Stages of Branchiooculofacial syndrome
Branchiooculofacial syndrome does not have defined progression stages. It is a congenital condition, so features are present from birth and can vary widely rather than unfolding in predictable steps. Different tests may be suggested to help confirm the diagnosis and plan care. Doctors typically use a physical exam, detailed family history, targeted eye and hearing evaluations, and sometimes genetic testing for the TFAP2A gene, and for some families, discussing early symptoms of Branchiooculofacial syndrome can help guide which specialists to see first.
Outlook and prognosis
Looking at the long-term picture can be helpful. Many people with Branchiooculofacial syndrome lead full lives, though the path often includes multiple surgeries and ongoing eye, ear, dental, and airway care. Even though it can feel overwhelming, coordinated follow-up with ENT, eye, dental, and craniofacial specialists usually keeps day-to-day issues manageable. Early care can make a real difference, especially for hearing, vision, and feeding challenges in infancy and childhood.
Prognosis refers to how a condition tends to change or stabilize over time. In Branchiooculofacial syndrome, life expectancy is generally near typical when serious airway or kidney problems are not present and infections are treated promptly. Some people experience lasting hearing loss or dry-eye symptoms, while others notice milder issues that respond well to glasses, hearing devices, eyelid lubrication, or minor procedures. The risk of vision loss is usually tied to corneal exposure from eyelid differences; protecting the eye surface early helps prevent long-term damage. When thinking about the future, it helps to watch for early symptoms of Branchiooculofacial syndrome that can affect feeding, breathing, or eye comfort in babies and young children, since timely treatment often prevents complications.
The outlook is not the same for everyone, but most challenges are stable after growth, with periodic tune-ups rather than constant crises. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, so a known TFAP2A change plus good sleep, dental hygiene, and infection prevention can all influence comfort and function. Talk with your doctor about what your personal outlook might look like, including plans for school supports, hearing technology, eye protection, and any future surgeries. With ongoing care, many people maintain active, independent lives into adulthood.
Long-term effects
Many living with Branchiooculofacial syndrome (BOFS) grow up with differences in the eyes, face, ears, and neck that can continue to shape day-to-day life into adulthood. Long-term effects vary widely, and no two people have the exact same pattern. The long-term outlook for Branchiooculofacial syndrome is shaped by which features are present at birth and how they change with growth. Some effects are stable, while others may shift over time as bones, teeth, and soft tissues mature.
Eye structure differences can lead to reduced vision or blindness in one or both eyes. Light sensitivity, depth-perception problems, and dry eye can persist.
Permanent conductive or mixed hearing loss is common due to ear-canal or middle-ear differences. Hearing levels can change over time and vary between ears.
Cleft lip and/or palate and nasal differences can leave long-term effects on speech clarity and resonance. Early feeding challenges often improve, but residual speech differences can remain.
Differences in the nose, upper lip, and midface can persist into adulthood. As the face grows, asymmetry or contour changes can become more noticeable.
How is it to live with Branchiooculofacial syndrome?
Living with Branchiooculofacial syndrome can mean juggling frequent medical visits and procedures, especially in childhood, to address features like cleft lip/palate, hearing differences, eye anomalies, and neck or ear pits that may get infected. Day to day, many manage speech therapy, hearing support, and dental or orthodontic care, while planning around surgeries and checkups; school and work are very possible with accommodations and a coordinated care team. Family members often become skilled advocates, helping with appointments and communication at school, and friends may need simple, honest explanations about visible differences to reduce curiosity and stigma. Over time, most families build routines that make care feel manageable, and connecting with specialists and peer communities can make a meaningful difference in confidence and quality of life.
Treatment and drugs
Branchiooculofacial syndrome treatment focuses on the specific features each person has, since the condition can affect the neck and ears, eyes, face, teeth, and sometimes growth or learning. You might picture this as a team effort between you and your doctor, often involving ENT and craniofacial surgeons for neck pits or cysts, eye specialists for blocked tear ducts or eyelid issues, dentists and orthodontists for cleft or palate problems, and speech therapy to support feeding and communication. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as antibiotics for infections in branchial cysts, eye drops or ointments for dry or irritated eyes, and pain control after procedures, while surgeries can repair structural problems and improve function and appearance. Regular hearing checks, eye exams, dental care, and developmental support help track progress and address new needs as children grow or adults’ priorities change. Ask your doctor about the best starting point for you, and how to coordinate care across specialists so your treatment plan stays clear and manageable.
Non-drug treatment
Branchiooculofacial syndrome care often centers on day-to-day function—feeding, breathing, hearing, vision, and speech—while planning for growth and development. Beyond prescriptions, supportive therapies can build skills and comfort from infancy through adulthood. Early symptoms of Branchiooculofacial syndrome are usually addressed by a coordinated team, and surgical and rehabilitative care are timed to your child’s needs and safety.
Repairing a cleft lip in early infancy and the palate later can make feeding easier and improve speech. Timing is individualized to support growth and reduce complications.
Surgery can remove small neck pits or tracts that drain or get infected. This helps prevent recurrent infections and improves comfort and appearance in Branchiooculofacial syndrome.
Early hearing checks guide the use of hearing aids, bone-conduction devices, or middle-ear procedures when needed. Classroom tools like FM systems and seating plans can make listening and learning easier.
Regular eye exams address dryness, light sensitivity, or eyelid and surface differences common in Branchiooculofacial syndrome. Glasses, eye lubrication, or patching can protect vision development.
Your genes may have an impact on how drugs work for you
Medicines used in branchiooculofacial syndrome can act differently depending on genes that affect drug processing, like enzymes in the liver that set dose needs or side‑effect risks. Genetic testing may guide choices for antibiotics, pain control, anesthesia, and scar‑modifying therapies.
Pharmacological treatments
Day-to-day care for Branchiooculofacial syndrome often focuses on easing eye irritation, protecting skin, and preventing infections around the head and neck. Early symptoms of Branchiooculofacial syndrome may involve eye dryness or frequent skin crusting, so medicines aim to keep surfaces comfortable and reduce flare-ups. Drugs that target symptoms directly are called symptomatic treatments. There’s no single disease-specific drug, so choices are tailored to each person’s eyes, skin, and any post‑surgical needs.
Preservative‑free artificial tears such as carboxymethylcellulose or hypromellose help relieve dryness and irritation. A thicker gel or petrolatum‑mineral oil ointment at night can protect the eye surface during sleep.
Erythromycin ophthalmic ointment can lower the risk of bacterial conjunctivitis when tear drainage is blocked. For active infections, doctors may use antibiotic drops such as moxifloxacin.
If eye pressure is high, timolol or latanoprost may be prescribed to protect vision. Regular pressure checks are essential, and side effects should be reviewed with your eye doctor.
For small, localized skin infections, mupirocin ointment is often used. Spreading or deeper infections may need oral antibiotics such as amoxicillin‑clavulanate, guided by culture when possible.
Genetic influences
Branchiooculofacial syndrome is caused by a change in a single gene called TFAP2A, which helps guide early development of the head, face, eyes, and neck. This gene acts like a developmental switch for these tissues, so when it’s altered, those structures may form differently. BOFS follows an autosomal dominant pattern—one altered copy is enough to cause the condition—yet many cases arise as a new (de novo) change with no prior family history. If a parent has BOFS, each child has a 50% chance of inheriting the gene change, though features can range from very mild to more complex even within the same family. Rarely, a parent without obvious signs may carry the change in a small proportion of cells (mosaicism), which can slightly increase the chance of another child being affected. Genetic testing that looks for TFAP2A changes can confirm the diagnosis and inform family planning; to put these pieces together, doctors may suggest genetic counseling.
Is Branchiooculofacial syndrome genetic?
Genetics are central in Branchiooculofacial syndrome, which is typically inherited in an autosomal dominant pattern. Most cases involve variations in the TFAP2A gene that alter facial, ear, eye, and neck development. Some arise from new (de novo) variants without family history.
Pharmacogenetics—how genetics influence drug effects
Care for Branchiooculofacial syndrome often involves surgeries, eye treatments, hearing support, and infection control, so medications for Branchiooculofacial syndrome commonly include anesthesia, pain relievers, antibiotics, and eye drops. The gene most often involved (TFAP2A) doesn’t by itself change how the body breaks down common medicines, but other everyday genetic differences can. Alongside medical history and surgical planning, genetic testing can help tailor medication choices. For example, variations in drug-processing genes may affect how well some pain medicines work or raise the chance of side effects, and rare inherited changes can increase sensitivity to certain anesthetics or muscle relaxants used in the operating room. If antibiotics are needed, testing may also flag a small group at higher risk for hearing damage with specific drugs, which matters for people with existing hearing concerns. Because kidney health can be affected in some people with Branchiooculofacial syndrome, dose adjustments based on organ function remain essential, with pharmacogenetics as just one part of a broader safety check. If you’re considering pharmacogenetic testing for Branchiooculofacial syndrome, talk with your care team about timing so results are available before planned procedures.
Interactions with other conditions
Living day-to-day with Branchiooculofacial syndrome often involves managing features that can interact with other health issues, like hearing loss, eye surface problems, or kidney differences. Ear canal and middle-ear changes can make ear infections more frequent, and cleft lip or palate may increase sinus and respiratory infections, which in turn can delay healing after surgeries. Eye surface dryness or tear‑duct blockage can lead to repeated eye infections, so treatments for one issue (like antibiotic drops) may need to be timed around other care. Kidney or heart differences, when present, can affect anesthesia plans and dosing of certain medicines, so coordinated care before procedures is important. Certain diseases may “overlap,” meaning BOFS can look similar to conditions such as branchio‑oto‑renal syndrome or CHARGE, and this can influence which specialists are involved and how family members are screened. If you live with BOFS and another condition, talk with your doctor about how your conditions may influence each other, especially around surgery, hearing support, and eye care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of babies born with small pits or tags along the neck and line of the jaw, eye differences, and distinctive facial features that seemed to run in certain family branches. Grandparents might recall an uncle who had early ear infections and a scar near the neck, while a new baby in the family showed similar signs. These observations came long before these features were grouped under one name.
First described in the medical literature as a cluster of branchial (neck), eye, and facial findings, the condition later took on the name Branchiooculofacial syndrome as doctors connected these separate features into a single pattern. Early reports focused on what could be seen and felt—neck cysts or fistulas that drained, unusual eyelid shapes, cleft lip, or broad nasal bridge—because imaging and genetic testing were limited. Over time, clinicians realized that hearing differences and dental anomalies were also common parts of the same picture.
From early case reports in the mid to late 20th century, specialists began tracking family histories and drawing family trees. In some families, the features appeared in every generation, which pointed to an autosomal dominant pattern—meaning a single altered copy of a gene could be enough to cause Branchiooculofacial syndrome. As more families were studied, the range of features turned out to be wider than first thought; some relatives had only subtle tags or small pits near the ears, while others had more obvious facial and eye differences.
With advances in genetics, researchers identified changes in a gene called TFAP2A as the main cause for most people with Branchiooculofacial syndrome. This gene helps guide early head and neck development, and the discovery tied decades of clinical observation to a clear biological explanation. Genetic testing then made it possible to confirm the diagnosis, help families understand inheritance, and support planning for hearing care, dental treatment, and surgery when needed.
Not every early description was complete, yet together they built the foundation of today’s knowledge. As medical science evolved, the name and criteria were refined, and the condition shifted from being considered rare and puzzling to a well-characterized syndrome that clinicians can recognize and manage. Today, the history of Branchiooculofacial syndrome reflects a steady path—from careful bedside observation, to family-based clues, to molecular confirmation—that continues to inform care and genetic counseling for those living with it.